Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 28, 2026 07:00 ET | Source: Trogenix

Trogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma

UK and US trial sites open; first patient dosed with TGX-007, Trogenix’s proprietary dual-payload AAV gene therapyTGX-007 leverages Trogenix’s precision synthetic super-enhancer platform that...
May 28, 2026 02:00 ET | Source: Trogenix

Trogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma

UK and US trial sites open; first patient dosed with TGX-007, Trogenix’s proprietary dual-payload AAV gene therapyTGX-007 leverages Trogenix’s precision synthetic super-enhancer platform that...